e-learning
resources
Berlin 2001
Sunday 23.09.2001
BAL / induced sputum / breath condensate in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Polymorphonuclear elastasa and collagenasa activity in patients with chronic obstructive pulmonary disease and acute bronchities
O. Sukhovskaya, N. Aleksandrova, N. Shklajrevich (Saint-Petersburg, Russia)
Source:
Annual Congress 2001 - BAL / induced sputum / breath condensate in lung disease
Session:
BAL / induced sputum / breath condensate in lung disease
Session type:
Thematic Poster Session
Number:
520
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Sukhovskaya, N. Aleksandrova, N. Shklajrevich (Saint-Petersburg, Russia). Polymorphonuclear elastasa and collagenasa activity in patients with chronic obstructive pulmonary disease and acute bronchities. Eur Respir J 2001; 16: Suppl. 31, 520
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Platelets count in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
IL-8 in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 364s
Year: 2001
Endothelial dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 89s
Year: 2002
The impact of anemia of chronic disease on exercise capacity among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011
Erythropoietin in chronic obstructive pulmonary disease patients without anemia
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Mortality in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
Chronic pain in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003
Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept